Global and China Nitinol-based Medical Device Market Insights, Forecast to 2027
SKU ID : QYR-18849233 | Publishing Date : 02-Aug-2021 | No. of pages : 153
Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc.
Global Nitinol-based Medical Device key players include Abbott, Medtronic, Boston Scientific, TERUMO, BD, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Guidewires is the largest segment, with a share over 45%. And in terms of application, the largest application is Vascular, followed by Orthopedic and Dental, etc.
Market Analysis and Insights: Global and China Nitinol-based Medical Device Market
This report focuses on global and China Nitinol-based Medical Device market.
In 2020, the global Nitinol-based Medical Device market size was US$ 18600 million and it is expected to reach US$ 36190 million by the end of 2027, with a CAGR of 10.2% during 2021-2027. In China the Nitinol-based Medical Device market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Nitinol-based Medical Device Scope and Market Size
Nitinol-based Medical Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nitinol-based Medical Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Nitinol-based Medical Device market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Stents
Guidewires
Others
The proportion of guidewires in 2018 is about 43%, and the proportion of stents in 2018 is about 7%.
Segment by Application
Vascular
Orthopedic and Dental
Others
Vascular segment accounted for larger market share in terms of sales in 2018, vascular segmented accounted for about 63.4% of the market share in 2018.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Edwards Lifesciences
Abbott
Boston Scientific
TERUMO
BD
Cordis
Cook Medical
B. Braun
Biotronik
Stryker
JOTEC
MicroPort
Acandis
ELLA-CS
Global Nitinol-based Medical Device key players include Abbott, Medtronic, Boston Scientific, TERUMO, BD, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Guidewires is the largest segment, with a share over 45%. And in terms of application, the largest application is Vascular, followed by Orthopedic and Dental, etc.
Market Analysis and Insights: Global and China Nitinol-based Medical Device Market
This report focuses on global and China Nitinol-based Medical Device market.
In 2020, the global Nitinol-based Medical Device market size was US$ 18600 million and it is expected to reach US$ 36190 million by the end of 2027, with a CAGR of 10.2% during 2021-2027. In China the Nitinol-based Medical Device market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Nitinol-based Medical Device Scope and Market Size
Nitinol-based Medical Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nitinol-based Medical Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Nitinol-based Medical Device market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Stents
Guidewires
Others
The proportion of guidewires in 2018 is about 43%, and the proportion of stents in 2018 is about 7%.
Segment by Application
Vascular
Orthopedic and Dental
Others
Vascular segment accounted for larger market share in terms of sales in 2018, vascular segmented accounted for about 63.4% of the market share in 2018.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Edwards Lifesciences
Abbott
Boston Scientific
TERUMO
BD
Cordis
Cook Medical
B. Braun
Biotronik
Stryker
JOTEC
MicroPort
Acandis
ELLA-CS
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.